AstraZeneca - Research-Based BioPharmaceutical Company
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
Working at AstraZeneca
Join our Talent Network Be the first to receive job updates and news from AstraZeneca Sign up
A timeline of our company history | AstraZeneca
AstraZeneca was founded in 1999 through the merger of Sweden's Astra AB and the UK's Zeneca Group PLC. This strategic merger combined each company’s strengths to drive …
Press Releases - AstraZeneca
Find press releases and media updates covering our latest science news, alongside AstraZeneca's financial, corporate, partnering and sustainability updates.
Singapore - AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, …
AstraZeneca plans to invest $50 billion in America for medicines ...
Jul 21, 2025 · We are proud that AstraZeneca has made the decision to bring substantial pharmaceutical production to our shores. This historic investment is bringing tens of thousands …
Introducing AstraZeneca R&D
AstraZeneca R&D: Turning science into medicine Introducing AstraZeneca R&D We are driven by science, united by science, and every day, we push the boundaries of science to deliver life …
About us - AstraZeneca
AstraZeneca aims to transform the treatment of asthma and chronic obstructive pulmonary disease (COPD) by eliminating preventable asthma attacks across all severities and removing …
Annual report 2024 - astrazeneca.com
Our performance AstraZeneca sustained strong momentum in 2024, with Total Revenue up 18% (21% at CER) and Reported EPS up 18% (29% at CER). Core EPS was up 13% (19% at CER).
AstraZeneca in the U.S.
At AstraZeneca, we believe in the power of what science can do. As a global, science-led biopharmaceutical company, AstraZeneca is focused on the discovery, development, and …